Analysed PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) News Sources
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
01-04-2026
yahoo.com
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
04-11-2025
yahoo.com
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
16-09-2025
yahoo.com
Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
08-09-2025
yahoo.com
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
29-08-2025
yahoo.com
Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
28-08-2025
yahoo.com
Pasithea Therapeutics Completes Enrollment and Initial Dosing of First Cohort from its Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
31-07-2025
yahoo.com
Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board
11-06-2025
yahoo.com
Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025
02-06-2025
yahoo.com
What is the current price of PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ)?
The current price of PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) is $0.0071.
PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) since the previous trading day is $0.
PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ)?
The most recent average sentiment score for PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ)?
The most recent sentiment for PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ) is .
SEC-8K** Filing Available For PASITHEA THERAPEUTICS -CW26 (KTTAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.